Loading…
Influx Healthtech (INFLUX)₹253.00−1.94%Pharmaceuticals
At the end of the Mar 2026 quarter, Influx Healthtech's shareholders were: promoters 73.49%, FIIs 0.16%, DIIs 5.70%, public 20.65%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 1,336 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|
| Promoters | 73.49% | 73.49% | 73.49% |
| FIIs | 3.37% | 1.82% | 0.16% |
| DIIs | 10.51% | 6.88% | 5.70% |
| Public | 12.63% | 17.81% | 20.65% |
| Promoter shares pledged | — | — | 0.00% |
| Number of shareholders | 2,404 | 1,023 | 1,336 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Munir Abdul Ganee Chandniwala | Promoter | 69.72% | — |
| Shirin Munir Ahmed Chandniwala | Promoter | 3.83% | — |
| Ccv Emerging Opportunities Fund-I | DII | 1.86% | — |
| Kulbhushan Parashar | Public | 1.85% | — |
| Aarth Aif Growth Fund | DII | 1.41% | — |
| Finavenue Capital Trust - Finavenue Growth Fund | DII | 1.34% | — |
Promoters held 73.49% of Influx Healthtech at the end of the Mar 2026 quarter.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held 0.16% (down 1.66 percentage points from 1.82% a quarter earlier) and domestic institutions (DIIs) held 5.70% (down 1.18 percentage points from 6.88% a quarter earlier).
No. The Mar 2026 filing shows no pledged promoter shares.
Influx Healthtech had 1,336 shareholders at the end of the Mar 2026 quarter.
Ccv Emerging Opportunities Fund-I (DII) held 1.86% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.